2 research outputs found
A Focus Group Study of Self-Management in Patients With Glomerular Disease
IntroductionPatients with glomerular disease experience symptoms that impair their physical and mental health while managing their treatments, diet, appointments and monitoring general and specific indicators of health and their illness. We sought to describe the perspectives of patients and their care partners on self-management in glomerular disease.MethodsWe conducted 16 focus groups involving adult patients with glomerular disease (n = 101) and their care partners (n = 34) in Australia, Hong Kong, the United Kingdom, and United States. Transcripts were analyzed thematically.ResultsWe identified the following 4 themes: empowered in autonomy (gaining confidence through understanding, taking ownership of disease and treatment, learning a positive health approach); overwhelmed by compounding treatment burdens (financially undermined and depleted, demoralized by side effects and harms, frustrated by fragmented and inflexible care, fear of possible drug harms); striving for stability and normalcy (making personal sacrifices, maximizing life participation, attentiveness to bodily signs, avoiding precarious health states, integrating medicines into routines); and necessity of health-sustaining relationships (buoyed by social support, fulfilling meaningful responsibilities, sharing and normalizing experiences, seeking a trusting and respectful alliance).ConclusionPatients with glomerular disease and their care partners value their capacity for autonomy and disease ownership, stability of their health, and relationships that support self-management. Strategies directed at strengthening these factors may increase self-efficacy and improve the care and outcomes for patients with glomerular disease
A Focus Group Study of Self-Management in Patients With Glomerular Disease
Introduction: Patients with glomerular disease experience symptoms that
impair their physical and mental health while managing their treatments,
diet, appointments and monitoring general and specific indicators of
health and their illness. We sought to describe the perspectives of
patients and their care partners on self-management in glomerular
disease.
Methods: We conducted 16 focus groups involving adult patients with
glomerular disease (n = 101) and their care partners (n = 34) in
Australia, Hong Kong, the United Kingdom, and United States. Transcripts
were analyzed thematically.
Results: We identified the following 4 themes: empowered in autonomy
(gaining confidence through understanding, taking ownership of disease
and treatment, learning a positive health approach); over-whelmed by
compounding treatment burdens (financially undermined and depleted,
demoralized by side effects and harms, frustrated by fragmented and
inflexible care, fear of possible drug harms); striving for stability
and normalcy (making personal sacrifices, maximizing life participation,
attentiveness to bodily signs, avoiding precarious health states,
integrating medicines into routines); and necessity of health-sustaining
relationships (buoyed by social support, fulfilling meaningful
responsibilities, sharing and normalizing experiences, seeking a
trusting and respectful alliance).
Conclusion: Patients with glomerular disease and their care partners
value their capacity for autonomy and disease ownership, stability of
their health, and relationships that support self-management. Strategies
directed at strengthening these factors may increase self-efficacy and
improve the care and outcomes for patients with glomerular disease